Table 2.
Relevant publications assessing human T cell immunity toward avian H5N1 and H7N9 influenza viruses.
Reference | Avian influenza subtype | T cells | Responses toward avian viruses |
---|---|---|---|
Jameson et al. (119) | H5N1 | CTLs reactive to H1N1, H2N2, and H3N2, obtained from healthy individuals from USA | Cross-reactivity with H5N1 |
Lee et al. (122) | H5N1 | CTLs reactive to H3N2 obtained from healthy individuals from Vietnam and UK | Cross-reactivity with H5N1 |
Goy et al. (120) | H5N1 | CTLs reactive to H1N1 and H3N2 obtained from healthy individuals from Australia | Cross-reactivity with H5N1 |
Kreijtz et al. (121) | H5N1 | In vitro expanded CTLs toward H3N2 obtained from healthy HLA-typed donors from the Netherlands | Cross-reactivity with H5N1-infected BLCL |
van de Sandt et al. (123) | H7N9 | CTLs expanded in vitro toward H1N1 (seasonal and pandemic) or H3N2 (seasonal) from healthy HLA-typed donors from the Netherlands | CTL cross-reactivity with H7N9-peptide loaded BLCLs |
Quinones-Parra et al. (124) | H7N9 | In vitro peptide-expanded PBMCs obtained from healthy HLA-typed individuals from Australia | CTL cross-reactivity with H7N9-derived immunogenic peptides is restricted by certain HLA haplotypes and varies across ethnicities |
Chen et al. (20) | H7N9 | PBMCs obtained from H7N9-infected patients in China | High numbers of peripheral blood T lymphocytes (CD4+ and CD8+) correlate with better clinical outcomes |
Wang et al. (22) | H7N9 | Ex vivo longitudinal analyses of PBMCs obtained from hospitalized H7N9-infected patients in Shanghai, China | Rapid recovery from H7N9 infection is associated with early CD8+ T cell responses |